-
J Pain Palliat Care Pharmacother · Jan 2007
The federal Drug Enforcement Administration "prescription series" proposal: continuing concerns.
- Aaron M Gilson and David E Joranson.
- U.S. Policy Research, World Health Organization Collaborationg Center for Policy and Communications in Cancer Care, University of Wisconsin-Madison, 406 Science Drive, Suite 202, Madison, WI 53711-1068, USA. amgilson@wisc.edu
- J Pain Palliat Care Pharmacother. 2007 Jan 1; 21 (4): 21-4.
AbstractTwo leading health and pain policy analysts discuss the implications of the federal Drug Enforcement Administration proposed position on the legality of practitioners writing series of controlled substance prescriptions for the purpose of providing ongoing pain management without the necessity for unneeded patient visits to their prescribers. This issue led to a series of regulatory proposals that engendered great concern in the pain management community. The proposed positive outcome from the DEA is described.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:
![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.